41. Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles. Issue 1 (1st January 2016) Authors: Gibson, Edward; Begum, Najida; Martinón-Torres, Federico; Safadi, Marco Aurélio; Sackeyfio, Alfred; Hackett, Judith; Rajaram, Sankarasubramanian Journal: Journal of market access & health policy Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients. Issue 1 (1st January 2019) Authors: Malone, Daniel C.; Dean, Rebecca; Arjunji, Ramesh; Jensen, Ivar; Cyr, Phil; Miller, Beckley; Maru, Benit; Sproule, Douglas M.; Feltner, Douglas E.; Dabbous, Omar Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy. Issue 1 (1st January 2017) Authors: Codecasa, Luigi R.; Toumi, Mondher; D'Ausilio, Anna; Aiello, Andrea; Damele, Francesco; Termini, Roberta; Uglietti, Alessia; Hettle, Robert; Graziano, Giorgio; De Lorenzo, Saverio Journal: Journal of market access & health policy Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK. Issue 1 (1st January 2018) Authors: Clay, Emilie; Jamotte, Aurélien; Verhamme, Peter; Cohen, Alexander T.; Van Hout, Ben. A.; Gumbs, Pearl. Journal: Journal of market access & health policy Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*. Issue 1 (1st January 2017) Authors: Borissov, Borislav; Urbich, Michael; Georgieva, Boryana; Tsenov, Svetoslav; Villa, Guillermo Journal: Journal of market access & health policy Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Cost-effectiveness of infant hypoallergenic formulas to manage cow's milk protein allergy in France. Issue 1 (31st December 2023) Authors: Paquete, Ana Teresa; Martins, Rui; Connolly, Mark P.; Meulle, Marie; Pastor, Nítida; Benoist, Grégoire; Tounian, Patrick Journal: Journal of market access & health policy Issue: Volume 11:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole. Issue 1 (1st January 2016) Authors: Bennison, Craig; Stephens, Stephanie; Lescrauwaet, Benedicte; Van Hout, Ben; Jackson, Timothy L. Journal: Journal of market access & health policy Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France. Issue 1 (1st January 2019) Authors: Clay, Emilie; Cristeau, Olivier; Chafaie, Romain; Pinta, Alexandrina; Mazaleyrat, Benjamin; Cottin, Vincent Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK. Issue 1 (1st January 2018) Authors: Hakimi, Zalmai; Kelleher, Con; Aballéa, Samuel; Maman, Khaled; Nazir, Jameel; Mankowski, Colette; Odeyemi, Isaac Journal: Journal of market access & health policy Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Cost-saving prediction model of transfer to palliative care for terminal cancer patients in a Japanese general hospital. Issue 1 (31st December 2022) Authors: Hashimoto, Yuki; Hayashi, Akitoshi; Tonegawa, Takashi; Teng, Lida; Igarashi, Ataru Journal: Journal of market access & health policy Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗